Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  

LabCorp might be able to charge a licensing fee to any scientists who wish to sequence the gene HOMER1 in people who may have autism.

In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.

An investigation of 2.7 million patent submissions in the U.S. finds gender disparities throughout the application process.

This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.

In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.

Gender discrimination, Brexit, and climate change are among the issues that have received considerable attention from the scientific community this year.

Hurricanes, protests, and lifesaving genetic engineering: our picks for the biggest stories of the year

The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.